Happy Holidays from all of us at ICON. We’re sending every best wish for health, happiness and success in 2026.
- Home
- News & Events
- In the News
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Pivoting toward sustainable supply chains in clinical research
In this article from Applied Clinical Trials, Kelly Corkey, Director, Clinical Supplies Management, IRT and Leonard Wee, VP, Global Supply Chain, Laboratories outline how by adopting a holistic approach that optimises each component of the process, the clinical research industry can collectively drive progress and pivot toward a greener future while continuing to support patient-centred clinical research.
-
Say Hello to Flexible: Reimagining the Patient Journey
In this article, Adam Halbridge Clinical Trial Tokenisation Lead and Executive Director, describes how flexibility is reimagining the patient journey and rebalancing the workload for each stakeholder involved.
-
Turning clinical research into virtual capacity
In this article in The Journal of mHealth, Madelaine MacKay, Senior Director, Product Management outlines that to keep patients and care provider needs at the core, four elements should be considered when adopting modern clinical trial approaches: flexibility, consistency, creativity, simplicity.
-
Early protocol assessment for increased patient centricity
In this article in Applied Clinical Trials, Emily Mitchell, Executive Director, eClinical Development and Delivery, outlines how thorough assessment of protocols, whether for DCTs or hybrid clinical trials that incorporate decentralised components, can ensure that studies are designed to minimise patient burden while optimising opportunities to leverage data on a wider scale.
-
Implications of regulatory and FDA guidance on diversity, equity and inclusion on clinical research study sites
Following discussions at the 2023 Global Site Solutions Summit, Missy Gottschlich, Director of Site Networks for Accellacare, provides key insights on how sites can implement regulatory guidelines on diversity, equity and inclusivity in this article in pharmaphorum.
-
Considerations for safety data migration methods
In this article, Graeme Bones, Director of Pharmacovigilance, explains how to handle the different types of data migration methods and how companies can select the optimum approach to ensure data integrity is maintained.
-
Improving health equity and diversity throughout the life sciences
As life sciences companies look for ways to improve diversity, equity and inclusion both within their organisations and in healthcare as a whole,PM360turned to 10 experts in the space to ask them how. In this article, Joshua Bueller, Account VP and Senior Strategy Consultant at ICON, describes how pharma companies can gain a better understanding into the needs of underrepresented and underserved groups using a patient-centric, data-driven approach.
-
Clinical Data Management
In this article, Michael Phillips, discusses the ways in which machine learning can replace or augment traditional data review approaches while maintaining a risk-based, patient-centric approach and delivering higher quality outcomes with less human error.
-
Providing support throughout the patient journey
Concierge services are critical to helping patients navigate technology and other logistics in a decentralised clinical trial. Laney Preheim outlines how they can best be implemented.
This article is taken fromInnovations in Pharmaceutical Technology, October 2022, pages 34-36 . Samedan Ltd
-
Longitudinal qualitative research - Capturing the patient voice; enhancing patient centricity
Outcomes researchers Alexia Marrel and Sally Lanar share insights on longitudinal qualitative research - what it is, when and how it can be used and the key factors for success when using this type of research.